chr16-1153791-G-A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7

The NM_021098.3(CACNA1H):​c.54G>A​(p.Pro18Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000278 in 1,078,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. P18P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0440

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-1153791-G-A is Benign according to our data. Variant chr16-1153791-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2939506.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.044 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.54G>A p.Pro18Pro synonymous_variant Exon 2 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.54G>A non_coding_transcript_exon_variant Exon 2 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
AF:
0.00000278
AC:
3
AN:
1078738
Hom.:
0
Cov.:
32
AF XY:
0.00000195
AC XY:
1
AN XY:
511980
show subpopulations
African (AFR)
AF:
0.0000453
AC:
1
AN:
22064
American (AMR)
AF:
0.00
AC:
0
AN:
7686
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13452
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24444
South Asian (SAS)
AF:
0.00
AC:
0
AN:
24940
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21868
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2832
European-Non Finnish (NFE)
AF:
0.00000218
AC:
2
AN:
918740
Other (OTH)
AF:
0.00
AC:
0
AN:
42712
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Nov 24, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
12
DANN
Benign
0.92
PhyloP100
0.044
PromoterAI
0.045
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1337167126; hg19: chr16-1203791; API